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Introdução: As mutações no gene PROP1 (Prophet of Pit-1) 
são a causa genética mais frequente de panhipopituitarismo, 
uma condição associada à deficiência ou produção inadequada 
de hormonas da hipófise anterior. O gene PROP1 codifica um 
factor de transcrição envolvido na ontogênese, diferenciação e 
função dos somatotrófos, lactotrófos, e tireotrófos. Estas mutações 
caracterizam-se por uma notável variabilidade clínica, incluindo 
o início do aparecimento das deficiências hormonais, dimensões 
hipofisárias e secreção de cortisol.
Caso clínico: Família de pais consanguíneos (primos em 
segundo grau), composta por 8 irmãos, 4 com o diagnóstico de 
panhipopituitarismo, seguidos em consulta de Endocrinologia, 
3 saudáveis e 1 nado-morto. Dois irmãos do sexo masculino, 41 e 
45 anos, com diagnóstico inicial de nanismo aos 9 e 12 anos de idade, 
respetivamente, tendo sido detetada posteriormente deficiência 
de TSH, FSH/LH e prolactina, em ambos e também de cortisol 
no último. As 2 irmãs têm 46 e 50 anos de idade e diagnóstico 
de panhipopituitarismo, com deficiência de GH, TSH, FSH/LH, 
prolactina e cortisol, aos 15 e aos 9 anos de idade, respetivamente. 
Sem história familiar prévia de panhipopituitarismo. Foi efectuado 
o estudo genético, tendo sido possível detectar nos 4 irmãos uma 
mutação homozigótica no gene PROP1 (c.301-302delAG).
Discussão: Esta família demontra descreve a variabilidade da 
expressão clínica e a progressiva alteração funcional hipofisária 
nomeadamente da secreção de cortisol nos portadores de mutações 
do gene PROP1.
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Objective: Cardiovascular (CV) disease is one of the most 
important causes of death in acromegalic patients (ACR). The aim 
of this study is to compare these CV risk factors between and a 
control population and to evaluate the effectiveness of control of the 
disease.
Methods: 10 ACR with active disease (ACRAct) and 12 with 
controlled disease (ACRCd) were evaluated for blood pressure (BP), 
body mass index (BMI), fasting glucose, coagulation status and 
lipidic profile. A group of 11 subjects with non-functioning pituitary 
adenomas was used as control population.
Results: ACRAct group had the highest mean BP, and ACRCd 
group the highest BMI. However, diastolic BP was lowest in ACRCd. 
Total cholesterol was slightly higher in ACRAct than controls (ns). 
When compared with ACRCt, the difference was significant (ACRAct 
having higher levels). HDL-C was higher in ACR, being significantly 
different between ACRCd and controls. Triglycerides were not 
significantly different among the three groups. Blood glucose 
was significantly higher in ACRCd and higher with borderline 
significance in ACRAct, when compared separately with control 
group. When categorizing patients as having hyperglycemia, 
hypertension and hyperlipidemia, higher percentages of all 
three variables were found in ACR when compared with controls. 
Significant correlation between those categories and the three 
studied groups was found only in hyperglycemia (p = 0.002). 
Regarding coagulat ion status, the f ibr inogen levels were 
significantly higher in ACR when compared with control group. 
ATIII was significantly higher in ACRAct when compared controls 
and ACRCd. When considering all ACR, signif icant positive 
correlation was found between ATIII and IGF-1 levels (r = 0.654; 
p = 0.001) and ATIII and GH levels (r = 0.498; p = 0.013). A positive, 
significant correlation was found between glucose levels and BMI 
(r = 0.478;p = 0.005) and glucose and SBP (r = 0.428; p = 0.013). 
Coagulation factor II levels were slightly higher in ACRAct than 
in controls and ACRCd (ns). When evaluating correlation among 
variables in all patients, a positive significant correlation was found 
between coagulation factor II and IGF-1 levels (r = 0.569, p = 0.004). 
A positive significant correlation was found between PAI-1 levels 
and BMI, coagulation factor VIII, ATIII and Protein C. Positive 
significant correlation was also found between coagulation factor 
II levels and fibrinogen and ATIIIT.
Conclusions: There is some reduction in CV risk factors with 
control of the disease, but possibly without return to basal levels.
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Introduction: Cushing`s Syndrome (CS) can be ACTH-dependent, 
caused by ACTH-secreting pituitary and ectopic tumors, or 
AC TH-independent , caused by cor t isol-secret ing adrenal 
tumors. The ectopic secretion of ACTH represents around 10% of 
ACTH-dependent CS and some remain unknown, even with the 
currently available imaging studies.
Case report: A 41 year-old woman, with a past history of 
DM, dyslipidemia, polyarthralgias, presented with complaints 
of weight gain (20 kg), hirsutism and depression. Physical exam 
showed typical cushingoid appearence. Endocrine studies 
showed elevated 24-h UFC (522 mg/24h) with basal AC TH 
29,2 ng/L , overnight 1 mg dexamethasone suppression test 
of 29.2 ug/L. She also had non-suppressible cortisol levels in a 
standard two-day 2 mg test. CRH stimulation test was positive. 
P ituitar y MR I was normal and bilateral Infer ior Petrosal 
Sinus Sampling had no central to peripheral ACTH gradient. 
Cervico-thoracic MRI scan was normal and abdominal MRI 
revealed a left adrenal nodule. Octreoscan showed one small left 
adrenal nodule and an uptake on the right thyroid lobe. FNA of 
the thyroid nodule showed colloid nature. PET-DOTA-NOC was 
unremarkable. Considering the severity of the symptoms she was 
started on methyrapone in increasing dosis and ketoconazole. Six 
months later she repeated the Octreoscan, showing the thyroid 
nodule, but failing to reveal the left adrenal nodule. Thoracic CT 
scans with Mini MIp reconstruction of the “respiratory tree” 
were normal. 18 months later she was submitted to bilateral 
laparoscopic adrenalectomy. The pathological exam showed 
a macroscopic (1.9 cm) adenoma on the r ight adrenal and 
microscopic adenoma on the left adrenal.
Conclusions: Despite advances in laboratory and imaging 
techniques, CS from ectopic ACTH secretion remains a difficult 
diagnostic and therapeutic challenge. It is essential, however, that 
patients treated with medication and palliative adrenalectomy 
pursue imaging studies to locate the tumor because of a small, but 
real chance of malignancy.
